Prophylactic phenylephrine infusion versus treatment with vasopressor bolus as needed during non-urgent cesarean delivery and neonatal acidemia: a retrospective cohort study (2016-2021).

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Additional Information
    • Source:
      Publisher: Elsevier Country of Publication: Netherlands NLM ID: 9200430 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-3374 (Electronic) Linking ISSN: 0959289X NLM ISO Abbreviation: Int J Obstet Anesth Subsets: MEDLINE
    • Publication Information:
      Publication: <2004->: Amsterdam, The Netherlands : Elsevier
      Original Publication: Edinburgh ; New York : Churchill Livingstone, c1991-
    • Subject Terms:
      Phenylephrine*/therapeutic use ; Phenylephrine*/administration & dosage ; Vasoconstrictor Agents*/therapeutic use ; Vasoconstrictor Agents*/administration & dosage ; Cesarean Section* ; Acidosis*/prevention & control; Humans ; Retrospective Studies ; Female ; Infant, Newborn ; Pregnancy ; Adult ; Cohort Studies ; Anesthesia, Spinal/methods ; Infusions, Intravenous ; Hypotension/prevention & control ; Hypotension/drug therapy ; Hypotension/epidemiology ; Anesthesia, Obstetrical/methods
    • Abstract:
      Introduction: Prophylactic vasopressor administration reduces spinal hypotension during cesarean delivery, however the effects of vasopressor administration on neonatal acidemia remain uncertain. We examined the occurrence of neonatal acidemia in the setting of non-urgent cesarean delivery and compared outcomes between cases receiving prophylactic phenylephrine infusion versus cases treated with boluses of phenylephrine.
      Methods: Retrospective cohort study with ethical approval, comparing non-urgent cesarean delivery cases performed under spinal anesthesia (2016 to 2021), receiving either prophylactic phenylephrine infusion or boluses as needed. Data were collected from anesthesia and labor ward electronic medical records. Records with missing pH or missing blood pressure data were excluded. The independent variable was prophylactic phenylephrine administration, a strategy implemented following international recommendations in 2018. The main outcome was neonatal acidemia, defined as umbilical artery pH < 7.1. The secondary outcome was maternal hypotension, defined as at least one systolic blood pressure (SBP) measurement below 100 mmHg or below 80% baseline.
      Results: A total of 4392 patients were included in the final analysis; 1318 (30.0%) received prophylactic phenylephrine infusion. Neonatal acidemia (umbilical artery pH < 7.1) occurred in 28 (2.1%) cases receiving prophylactic phenylephrine versus 50 (1.6%) treated with boluses as needed (p = 0.188). Prophylactic phenylephrine infusion was not associated with occurrence of neonatal acidemia (aOR 0.83; 95% CI 0.52 to 1.33, p = 0.435). Prophylactic phenylephrine infusion was associated with a reduced spinal hypotension rate when defined as SBP < 100 mmHg (OR 0.47; 95% CI 0.37 to 0.57; p < 0.001), with similar results when hypotension was defined as a drop below 80% or 90% of baseline SBP.
      Conclusion: In this pragmatic study, prophylactic phenylephrine infusion was associated with a reduction in maternal spinal hypotension, but not reduced neonatal acidemia.
      (Copyright © 2024 Elsevier Ltd. All rights reserved.)
    • Contributed Indexing:
      Keywords: Cesarean delivery; Neonatal acidemia; Phenylephrine infusion; Prophylactic vasopressor; Spinal hypotension
    • Accession Number:
      1WS297W6MV (Phenylephrine)
      0 (Vasoconstrictor Agents)
    • Publication Date:
      Date Created: 20240911 Date Completed: 20241019 Latest Revision: 20241019
    • Publication Date:
      20241020
    • Accession Number:
      10.1016/j.ijoa.2024.104253
    • Accession Number:
      39260084